ASEP Medical Holdings Inc.
ASEP
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -51.69% | -20.53% | -24.91% | 138.72% | 91.33% |
| Depreciation & Amortization | -1.69% | 0.04% | 2.41% | 1.86% | -1.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -46.80% | -23.83% | -30.21% | 47.08% | 59.84% |
| Operating Income | 51.78% | 28.02% | 35.73% | -45.06% | -59.84% |
| Income Before Tax | 42.19% | 53.30% | 58.15% | -39.28% | -38.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.19% | 53.30% | 58.15% | -47.32% | -38.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.04% | -35.57% | -41.86% | -20.01% | -20.41% |
| Net Income | 45.18% | 55.61% | 60.64% | -65.24% | -70.19% |
| EBIT | 51.78% | 28.02% | 35.73% | -45.06% | -59.84% |
| EBITDA | 65.69% | 34.14% | 47.27% | -60.96% | -93.62% |
| EPS Basic | 54.55% | 65.05% | 68.85% | -39.62% | -49.51% |
| Normalized Basic EPS | 56.10% | 51.22% | 56.38% | -70.69% | -86.36% |
| EPS Diluted | 54.55% | 65.05% | 68.85% | -39.62% | -49.51% |
| Normalized Diluted EPS | 56.10% | 51.22% | 56.38% | -70.69% | -86.36% |
| Average Basic Shares Outstanding | 20.13% | 27.46% | 26.96% | 18.28% | 13.37% |
| Average Diluted Shares Outstanding | 20.13% | 27.46% | 26.96% | 18.28% | 13.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
